EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A PHF19-YTHDC1 condensate switches EZH2-mediated gene suppression to activation for prostate cancer progression

Shuai Yuan iD, Dao-Jing Ming iD, Jiapeng He, Meng-Yang Liu, Shao-Hua He, Hong Weng iD, Shu Xi, Jin-Hui Zhang, Ming-Hui Shi, Jin-Long Cui, Lu-Yao Li, Haozhe Zhang und 9 weitere

Proceedings of the National Academy of Sciences · 28.10.2025 · 122 (43)

DOI: 10.1073/pnas.2510386122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 23.10.2025. Verfasst von Shuai Yuan und 20 weiteren Autor:innen. Beteiligte Einrichtung: Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, China. Hauptthemen laut MEDLINE: Enhancer of Zeste Homolog 2 Protein, Prostatic Neoplasms, Transcription Factors, DNA-Binding Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), | Natural Science Foundation of Hubei Province (), 湖北省科技厅 | Natural Science Foundation of Hubei Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

EZH2, a core component of PRC2 complex, silences global gene expression by tri-methylating histone H3K27. It remains an elusive question that EZH2 hyperexpression discords with its H3K27me3 activity of gene suppression in advanced prostate cancer. Here, we report a nascent RNA-dependent PHF19-YTHDC1 condensate capable of switching EZH2-mediated gene suppression to activation during prostate cancer progression. We found that the long isoform of PRC2 accessory subunit PHF19, PHF19L, was highly expressed in advanced prostate cancer that promoted the tumor progression and hormonal therapy resistance. Mechanistically, PHF19L was recruited to the m 6 A modified nascent RNA through YTHDC1 and formed a liquid-like YTHDC1-PHF19L condensate that pulled the EZH2 away from chromatin, resulting in reduced H3K27me3 deposition and the activated expression of EZH2-repressed genes. Therefore, our study reveals a biomolecular condensate that modulates the switch from EZH2-mediated epigenetic gene silence to activation during the progression of prostate cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Enhancer of Zeste Homolog 2 ProteinProstatic NeoplasmsTranscription FactorsDNA-Binding ProteinsMaleHumansGene Expression Regulation, NeoplasticDisease ProgressionCell Line, TumorHistonesEpigenesis, Genetic

Stichwörter der Autor:innen

EZH2YTHDC1liquid–liquid phase separationnascent RNAprostate cancer

Substanzen

Enhancer of Zeste Homolog 2 ProteinEZH2 protein, humanTranscription FactorsPHF19 protein, humanDNA-Binding ProteinsHistones

Autor:innen und Institutionen

  • Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
  • Hubei Key Laboratory of Urinary System Diseases, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
  • Department of Biochemistry, SUSTech Homeostatic Medicine Institute, School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong 518000, China.
  • Precision Medicine Center, The Second People's Hospital of Huaihua (Huaihua Cancer Hospital), Huaihua 418000, China.
  • Department of Epidemiology and Biostatistics, School of Public Health, Wuhan University, Wuhan 430071, China.

ORCID-Profile: Shuai Yuan, Dao-Jing Ming, Hong Weng, Fei Li, Xian-Tao Zeng, Hailiang Hu

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)
  • | Natural Science Foundation of Hubei Province ()
  • 湖北省科技厅 | Natural Science Foundation of Hubei Province

Zitieren

APA

Yuan, S., Ming, D. J., He, J., Liu, M. Y., He, S. H., Weng, H., Xi, S., Zhang, J. H., Shi, M. H., Cui, J. L., Li, L. Y., Zhang, H., Wang, D. Q., Li, F., Guo, M. M., Cai, Y., Tang, S. D., Wang, S. Y., Wang, X. H., …, & Hu, H. (2025). A PHF19-YTHDC1 condensate switches EZH2-mediated gene suppression to activation for prostate cancer progression. Proceedings of the National Academy of Sciences, 122(43). https://doi.org/10.1073/pnas.2510386122

Vancouver

Yuan S, Ming DJ, He J, Liu MY, He SH, Weng H, et al. A PHF19-YTHDC1 condensate switches EZH2-mediated gene suppression to activation for prostate cancer progression. Proceedings of the National Academy of Sciences. 2025;122(43). doi:10.1073/pnas.2510386122

BibTeX
@article{Yuan2025,
  author = {Yuan, Shuai and Ming, Dao-Jing and He, Jiapeng and Liu, Meng-Yang and He, Shao-Hua and Weng, Hong and Xi, Shu and Zhang, Jin-Hui and Shi, Ming-Hui and Cui, Jin-Long and Li, Lu-Yao and Zhang, Haozhe and Wang, Dan-Qi and Li, Fei and Guo, Meng-Meng and Cai, Yi and Tang, Shi-Di and Wang, Shuang-Ying and Wang, Xing-Huan and Zeng, Xian-Tao and Hu, Hailiang},
  title = {A PHF19-YTHDC1 condensate switches EZH2-mediated gene suppression to activation for prostate cancer progression},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  volume = {122},
  number = {43},
  doi = {10.1073/pnas.2510386122}
}
Kostenlos starten →